Skip to main content
Top
Published in: Calcified Tissue International 1/2017

01-01-2017 | Original Research

Delineating the Relationship Between Leptin, Fat Mass, and Bone Mineral Density: A Mediation Analysis

Authors: Lan T. Ho-Pham, Thai Q. Lai, Uyen D. T. Nguyen, Quoc V. Bui, Tuan V. Nguyen

Published in: Calcified Tissue International | Issue 1/2017

Login to get access

Abstract

To test the hypothesis that the relationship between fat mass (FM) and bone mineral density (BMD) is mediated by leptin. The study involved 611 individuals aged 20–89 years who were randomly sampled from Ho Chi Minh City (Vietnam). BMD at the femoral neck (FN), lumbar spine (LS), and whole body (WB) was measured by DXA. Lean mass and FM were derived from the WB DXA scan. Leptin was measured by ELISA (DRG Diagnostics, Germany). The regression method was used to partition the variance of leptin and FM on BMD. The mediated effect of leptin was analyzed by the mediation analysis model. In the multiple linear regression, leptin, FM, and age collectively accounted for ~34 % variation in FNBMD in men and women. However, only 0.5 % of this explained variance was due to leptin. Of the total effect of FM on FNBMD, the mediated effect of leptin accounted for 6.1 % (P = 0.38) in men and 7.1 % (P = 0.99) in women. The same trend was observed for LS and WBBMD. These data suggest that greater FM is associated with greater BMD, but the association is not mediated by leptin, and that leptin has a non-significant influence on bone mass.
Literature
1.
go back to reference Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359(9319):1761–1767PubMedCrossRef Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359(9319):1761–1767PubMedCrossRef
2.
go back to reference Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312(7041):1254–1259PubMedPubMedCentralCrossRef Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312(7041):1254–1259PubMedPubMedCentralCrossRef
3.
go back to reference Chan MY, Frost SA, Center JR, Eisman JA, Nguyen TV (2014) Relationship between body mass index and fracture risk is mediated by bone mineral density. J Bone Miner Res 29(11):2327–2335PubMedCrossRef Chan MY, Frost SA, Center JR, Eisman JA, Nguyen TV (2014) Relationship between body mass index and fracture risk is mediated by bone mineral density. J Bone Miner Res 29(11):2327–2335PubMedCrossRef
4.
go back to reference Nguyen TV, Howard GM, Kelly PJ, Eisman JA (1998) Bone mass, lean mass, and fat mass: same genes or same environments? Am J Epidemiol 147(1):3–16PubMedCrossRef Nguyen TV, Howard GM, Kelly PJ, Eisman JA (1998) Bone mass, lean mass, and fat mass: same genes or same environments? Am J Epidemiol 147(1):3–16PubMedCrossRef
5.
go back to reference Ho-Pham LT, Nguyen ND, Lai TQ, Nguyen TV (2010) Contributions of lean mass and fat mass to bone mineral density: a study in postmenopausal women. BMC Musculoskelet Disord 11:59PubMedPubMedCentralCrossRef Ho-Pham LT, Nguyen ND, Lai TQ, Nguyen TV (2010) Contributions of lean mass and fat mass to bone mineral density: a study in postmenopausal women. BMC Musculoskelet Disord 11:59PubMedPubMedCentralCrossRef
6.
go back to reference Holloway WR, Collier FM, Aitken CJ, Myers DE, Hodge JM, Malakellis M et al (2002) Leptin inhibits osteoclast generation. J Bone Miner Res 17(2):200–209PubMedCrossRef Holloway WR, Collier FM, Aitken CJ, Myers DE, Hodge JM, Malakellis M et al (2002) Leptin inhibits osteoclast generation. J Bone Miner Res 17(2):200–209PubMedCrossRef
7.
go back to reference Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y et al (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1(11):1155–1161PubMedCrossRef Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y et al (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1(11):1155–1161PubMedCrossRef
8.
go back to reference Ho-Pham LT, Nguyen UD, Nguyen TV (2014) Association between lean mass, fat mass, and bone mineral density: a meta-analysis. J Clin Endocrinol Metab 99(1):30–38PubMedCrossRef Ho-Pham LT, Nguyen UD, Nguyen TV (2014) Association between lean mass, fat mass, and bone mineral density: a meta-analysis. J Clin Endocrinol Metab 99(1):30–38PubMedCrossRef
9.
go back to reference Bartell SM, Rayalam S, Ambati S, Gaddam DR, Hartzell DL, Hamrick M et al (2011) Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression of osteogenic genes in leptin-deficient ob/ob mice. J Bone Miner Res 26(8):1710–1720PubMedCrossRef Bartell SM, Rayalam S, Ambati S, Gaddam DR, Hartzell DL, Hamrick M et al (2011) Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression of osteogenic genes in leptin-deficient ob/ob mice. J Bone Miner Res 26(8):1710–1720PubMedCrossRef
10.
go back to reference Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334(5):292–295PubMedCrossRef Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334(5):292–295PubMedCrossRef
11.
go back to reference Elefteriou F, Takeda S, Ebihara K, Magre J, Patano N, Kim CA et al (2004) Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci USA 101(9):3258–3263PubMedPubMedCentralCrossRef Elefteriou F, Takeda S, Ebihara K, Magre J, Patano N, Kim CA et al (2004) Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci USA 101(9):3258–3263PubMedPubMedCentralCrossRef
12.
go back to reference Morberg CM, Tetens I, Black E, Toubro S, Soerensen TI, Pedersen O et al (2003) Leptin and bone mineral density: a cross-sectional study in obese and nonobese men. J Clin Endocrinol Metab 88(12):5795–5800PubMedCrossRef Morberg CM, Tetens I, Black E, Toubro S, Soerensen TI, Pedersen O et al (2003) Leptin and bone mineral density: a cross-sectional study in obese and nonobese men. J Clin Endocrinol Metab 88(12):5795–5800PubMedCrossRef
13.
go back to reference Sahin G, Polat G, Baethis S, Milcan A, Baethdatoethlu O, Erdoethan C et al (2003) Body composition, bone mineral density, and circulating leptin levels in postmenopausal Turkish women. Rheumatol Int 23(2):87–91PubMed Sahin G, Polat G, Baethis S, Milcan A, Baethdatoethlu O, Erdoethan C et al (2003) Body composition, bone mineral density, and circulating leptin levels in postmenopausal Turkish women. Rheumatol Int 23(2):87–91PubMed
14.
go back to reference Blain H, Vuillemin A, Guillemin F, Durant R, Hanesse B, de Talance N et al (2002) Serum leptin level is a predictor of bone mineral density in postmenopausal women. J Clin Endocrinol Metab 87(3):1030–1035PubMedCrossRef Blain H, Vuillemin A, Guillemin F, Durant R, Hanesse B, de Talance N et al (2002) Serum leptin level is a predictor of bone mineral density in postmenopausal women. J Clin Endocrinol Metab 87(3):1030–1035PubMedCrossRef
15.
go back to reference Thomas T, Burguera B, Melton LJ 3rd, Atkinson EJ, O’Fallon WM, Riggs BL et al (2001) Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women. Bone 29(2):114–120PubMedCrossRef Thomas T, Burguera B, Melton LJ 3rd, Atkinson EJ, O’Fallon WM, Riggs BL et al (2001) Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women. Bone 29(2):114–120PubMedCrossRef
16.
go back to reference Yamauchi M, Sugimoto T, Yamaguchi T, Nakaoka D, Kanzawa M, Yano S et al (2001) Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clin Endocrinol (Oxf) 55(3):341–347CrossRef Yamauchi M, Sugimoto T, Yamaguchi T, Nakaoka D, Kanzawa M, Yano S et al (2001) Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clin Endocrinol (Oxf) 55(3):341–347CrossRef
17.
go back to reference Ruhl CE, Everhart JE (2002) Relationship of serum leptin concentration with bone mineral density in the United States population. J Bone Miner Res 17(10):1896–1903PubMedCrossRef Ruhl CE, Everhart JE (2002) Relationship of serum leptin concentration with bone mineral density in the United States population. J Bone Miner Res 17(10):1896–1903PubMedCrossRef
18.
go back to reference Hadji P, Bock K, Gotschalk M, Hars O, Backhus J, Emons G et al (2003) The influence of serum leptin concentration on bone mass assessed by quantitative ultrasonometry in pre and postmenopausal women. Maturitas 44(2):141–148PubMedCrossRef Hadji P, Bock K, Gotschalk M, Hars O, Backhus J, Emons G et al (2003) The influence of serum leptin concentration on bone mass assessed by quantitative ultrasonometry in pre and postmenopausal women. Maturitas 44(2):141–148PubMedCrossRef
19.
go back to reference Blum M, Harris SS, Must A, Naumova EN, Phillips SM, Rand WM et al (2003) Leptin, body composition and bone mineral density in premenopausal women. Calcif Tissue Int 73(1):27–32PubMedCrossRef Blum M, Harris SS, Must A, Naumova EN, Phillips SM, Rand WM et al (2003) Leptin, body composition and bone mineral density in premenopausal women. Calcif Tissue Int 73(1):27–32PubMedCrossRef
20.
go back to reference Sato M, Takeda N, Sarui H, Takami R, Takami K, Hayashi M et al (2001) Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men. J Clin Endocrinol Metab 86(11):5273–5276PubMedCrossRef Sato M, Takeda N, Sarui H, Takami R, Takami K, Hayashi M et al (2001) Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men. J Clin Endocrinol Metab 86(11):5273–5276PubMedCrossRef
21.
go back to reference Slinker BK, Glantz SA (1985) Multiple regression for physiological data analysis: the problem of multicollinearity. Am J Physiol 249(1 Pt 2):R1–R12PubMed Slinker BK, Glantz SA (1985) Multiple regression for physiological data analysis: the problem of multicollinearity. Am J Physiol 249(1 Pt 2):R1–R12PubMed
22.
go back to reference Tu YK, Kellett M, Clerehugh V, Gilthorpe MS (2005) Problems of correlations between explanatory variables in multiple regression analyses in the dental literature. Br Dent J 199(7):457–461PubMedCrossRef Tu YK, Kellett M, Clerehugh V, Gilthorpe MS (2005) Problems of correlations between explanatory variables in multiple regression analyses in the dental literature. Br Dent J 199(7):457–461PubMedCrossRef
23.
go back to reference Thomas T, Burguera B (2002) Is leptin the link between fat and bone mass? J Bone Miner Res 17(9):1563–1569PubMedCrossRef Thomas T, Burguera B (2002) Is leptin the link between fat and bone mass? J Bone Miner Res 17(9):1563–1569PubMedCrossRef
24.
go back to reference Baron RM, Kenny DA (1986) The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51(6):1173–1182PubMedCrossRef Baron RM, Kenny DA (1986) The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51(6):1173–1182PubMedCrossRef
25.
go back to reference Tingley D, Yamamoto T, Hirose K, Keele L, Imai K (2014) Mediation: R package for causal mediation analysis. J Stat Softw 2014(5):1–38 Tingley D, Yamamoto T, Hirose K, Keele L, Imai K (2014) Mediation: R package for causal mediation analysis. J Stat Softw 2014(5):1–38
26.
go back to reference Grömping U (2007) Estimators of relative importance in linear regression based on variance decomposition. Am Stat 61:139–147CrossRef Grömping U (2007) Estimators of relative importance in linear regression based on variance decomposition. Am Stat 61:139–147CrossRef
27.
28.
go back to reference Gromping U (2006) Relative importance for linear regression in R: the package relaimpo. J Stat Softw 17(1):1–27CrossRef Gromping U (2006) Relative importance for linear regression in R: the package relaimpo. J Stat Softw 17(1):1–27CrossRef
29.
go back to reference Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT et al (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100(2):197–207PubMedCrossRef Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT et al (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100(2):197–207PubMedCrossRef
30.
go back to reference Reid IR, Plank LD, Evans MC (1992) Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. J Clin Endocrinol Metab 75(3):779–782PubMed Reid IR, Plank LD, Evans MC (1992) Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. J Clin Endocrinol Metab 75(3):779–782PubMed
31.
go back to reference Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D et al (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269(5223):543–546PubMedCrossRef Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D et al (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269(5223):543–546PubMedCrossRef
32.
go back to reference Felson DT, Zhang Y, Hannan MT, Anderson JJ (1993) Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res 8(5):567–573PubMedCrossRef Felson DT, Zhang Y, Hannan MT, Anderson JJ (1993) Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res 8(5):567–573PubMedCrossRef
33.
34.
go back to reference Pasco JA, Henry MJ, Kotowicz MA, Collier GR, Ball MJ, Ugoni AM et al (2001) Serum leptin levels are associated with bone mass in nonobese women. J Clin Endocrinol Metab 86(5):1884–1887PubMed Pasco JA, Henry MJ, Kotowicz MA, Collier GR, Ball MJ, Ugoni AM et al (2001) Serum leptin levels are associated with bone mass in nonobese women. J Clin Endocrinol Metab 86(5):1884–1887PubMed
35.
36.
go back to reference Dina C, Meyre D, Gallina S, Durand E, Korner A, Jacobson P et al (2007) Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 39(6):724–726PubMedCrossRef Dina C, Meyre D, Gallina S, Durand E, Korner A, Jacobson P et al (2007) Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 39(6):724–726PubMedCrossRef
37.
go back to reference Guo Y, Liu H, Yang TL, Li SM, Li SK, Tian Q et al (2011) The fat mass and obesity associated gene, FTO, is also associated with osteoporosis phenotypes. PLoS One 6(11):e27312PubMedPubMedCentralCrossRef Guo Y, Liu H, Yang TL, Li SM, Li SK, Tian Q et al (2011) The fat mass and obesity associated gene, FTO, is also associated with osteoporosis phenotypes. PLoS One 6(11):e27312PubMedPubMedCentralCrossRef
38.
go back to reference Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89(6):2548–2556PubMedCrossRef Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89(6):2548–2556PubMedCrossRef
39.
40.
go back to reference Hickey MS, Israel RG, Gardiner SN, Considine RV, McCammon MR, Tyndall GL et al (1996) Gender differences in serum leptin levels in humans. Biochem Mol Med 59(1):1–6PubMedCrossRef Hickey MS, Israel RG, Gardiner SN, Considine RV, McCammon MR, Tyndall GL et al (1996) Gender differences in serum leptin levels in humans. Biochem Mol Med 59(1):1–6PubMedCrossRef
41.
go back to reference Couillard C, Mauriege P, Prud’homme D, Nadeau A, Tremblay A, Bouchard C et al (1997) Plasma leptin concentrations: gender differences and associations with metabolic risk factors for cardiovascular disease. Diabetologia 40(10):1178–1184PubMedCrossRef Couillard C, Mauriege P, Prud’homme D, Nadeau A, Tremblay A, Bouchard C et al (1997) Plasma leptin concentrations: gender differences and associations with metabolic risk factors for cardiovascular disease. Diabetologia 40(10):1178–1184PubMedCrossRef
42.
go back to reference Hellstrom L, Wahrenberg H, Hruska K, Reynisdottir S, Arner P (2000) Mechanisms behind gender differences in circulating leptin levels. J Intern Med 247(4):457–462PubMedCrossRef Hellstrom L, Wahrenberg H, Hruska K, Reynisdottir S, Arner P (2000) Mechanisms behind gender differences in circulating leptin levels. J Intern Med 247(4):457–462PubMedCrossRef
Metadata
Title
Delineating the Relationship Between Leptin, Fat Mass, and Bone Mineral Density: A Mediation Analysis
Authors
Lan T. Ho-Pham
Thai Q. Lai
Uyen D. T. Nguyen
Quoc V. Bui
Tuan V. Nguyen
Publication date
01-01-2017
Publisher
Springer US
Published in
Calcified Tissue International / Issue 1/2017
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-016-0196-5

Other articles of this Issue 1/2017

Calcified Tissue International 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.